Home / Ambrisentan / Czechia
CZ ATC C02KX02 · updated 2 Nov 2026
Ambrisentan shortage in Czechia
Is there an Ambrisentan shortage in Czechia?
Yes. As of 2 Nov 2026, 1 Ambrisentan product is reported short in Czechia, the first since 15 Oct 2026. The company estimate for the return is 6 Jan 2027. Main reason: manufacturing problem.
Also short in Canada, France, Italy, Sweden, Australia. All countries.
Affected products in Czechia
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CZ | AMBRISENTAN ZENTIVA 10MG 10MG TBL FLM 30X1 I | Zentiva, k.s., Praha | 15 Oct 2026 | 6 Jan 2027 | Manufacturing problem Výrobní důvody |
Source
SÚKL (State Institute for Drug Control), market reports. Official list. Products whose latest market report is a supply interruption; one row per SÚKL code.